Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Anxiety and Work Resilience Among Tertiary University Hospital Workers During the COVID-19 Outbreak: An Online Survey (PSY_CO_CHU)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04358640
Recruitment Status : Recruiting
First Posted : April 24, 2020
Last Update Posted : April 24, 2020
Sponsor:
Information provided by (Responsible Party):
Centre Hospitalier Universitaire de Nīmes

Brief Summary:

For limiting COVID-19 spreading, the World Health Organisation (WHO) recommended worldwide confinement on 2010. In France, unessential institutions were closed on March 14th and population confinement was decided on March 17th.

Quarantine and/or confinement could lead to psychological effects such as confusion, suicide ideation, post-traumatic stress symptoms or anger COVID-19 outbreak highlighted a considerable proportion of health care workers (HCW) with depression, insomnia, anxiety and distress symptoms. In front line, facing the virus with the fear of contracting it and contaminate their closest. During previous outbreaks (H1N1, SARS), HCWs have been shown to experience such negative psychological effects of confinement as well as work avoidance behaviour and physical interaction reduction with infected patients (4-7).

In France, Covid 19 outbeak led to increase ICU bed capacity with a full reorganization of the human resources. Some caregivers were reassigned to newly setup units admitting or not Covid-19 patients. In the same time, non-caregivers were also encouraged to work at home whenever possible. Thus, every hospital staff member's private and professional life could be altered by the Covid-19 outbreak.

As all these changes in the daily life could induce psychological disturbances, the present study was aimed at assessing the acute anxiety level (main objective) of the staff in our Tertiary University Hospital, (6300 employees). Secondarily, the self-reported insomnia, pain, catastrophism and work avoidance behaviour levels were assessed


Condition or disease
Critical Illness Sars-CoV2 SARS Pneumonia Coronavirus Infection Stress Disorders, Post-Traumatic

Layout table for study information
Study Type : Observational
Estimated Enrollment : 2000 participants
Observational Model: Other
Time Perspective: Prospective
Official Title: Anxiety and Work Resilience Among Tertiary University Hospital Workers During the COVID-19 Outbreak: An Online Survey
Actual Study Start Date : April 9, 2020
Estimated Primary Completion Date : April 22, 2020
Estimated Study Completion Date : April 22, 2020

Resource links provided by the National Library of Medicine


Group/Cohort
Employees of Nîmes University Hospital (France)
Employees of Nîmes University Hospital (France)



Primary Outcome Measures :
  1. Anxiety [ Time Frame: 15 to 45 days after the beginning of the outbreak ]
    Mesured by STAY Scale


Secondary Outcome Measures :
  1. Insomnia [ Time Frame: 15 to 45 days after the beginning of the outbreak ]
    Participant suffering of Insomnia

  2. Catastrophism [ Time Frame: 15 to 45 days after the beginning of the outbreak ]
    Participant suffering of catastrophism



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
All employees of ICHU Nîmes participating to the present study will be sent a questionnaire for assessing the potential occurrence of anxiety This evaluation will be performed after the beginning of the outbreak (15 to 45 days)
Criteria

Inclusion Criteria:

  • Employees of CHU Nîmes during COVID-19 pandemic
  • Approved to participate

Exclusion Criteria:

• Participation refusal


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04358640


Contacts
Layout table for location contacts
Contact: Jean-Yves LEFRANT +33466683331 jean.yves.lefrant@chu-nimes.fr

Locations
Layout table for location information
France
Intensive care unit CHU Nimes Recruiting
Nîmes, France, 30029
Contact: Jean-Yves Lefrant, MD,PhD    +33466683331    jean.yves.lefrant@chu-nimes.fr   
Principal Investigator: Jean-Yves LEFRANT, MD,PhD         
Sponsors and Collaborators
Centre Hospitalier Universitaire de Nīmes
Publications:
Layout table for additonal information
Responsible Party: Centre Hospitalier Universitaire de Nīmes
ClinicalTrials.gov Identifier: NCT04358640    
Other Study ID Numbers: LOCAL COVID 2019/JYL-01)
First Posted: April 24, 2020    Key Record Dates
Last Update Posted: April 24, 2020
Last Verified: April 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Coronavirus Infections
Severe Acute Respiratory Syndrome
Pneumonia
Critical Illness
Stress Disorders, Post-Traumatic
Lung Diseases
Respiratory Tract Diseases
Respiratory Tract Infections
Stress Disorders, Traumatic
Trauma and Stressor Related Disorders
Mental Disorders
Coronaviridae Infections
Nidovirales Infections
RNA Virus Infections
Virus Diseases
Disease Attributes
Pathologic Processes